By downregulating NF-κB, RES reduces the release of pro-inflammatory cytokines from glial cells, alleviating neuroinflammation and oxidative stress—processes that are critically involved in the pathophysiology of stress-related anxiety disorders. This evidence concerns the gene NFKB1 and anxiety disorder.